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Foreword 
This paper deals with mathematical modelling and related data processing from im- 
munological tests for oncological patients. A model for describing the dynamics of the ob- 
served data is given. A method for investigating mortality dynamics as a function of in- 
specting clinical indices is suggested. This approach is then uaed for an analysis of immu- 
nological data from patients with stomach cancer. 
The results may be useful for estimating the state of the organism during disease and 
for solving a related optimal control problem. The solution may be interpreted as a 
recommendation for therapy. 
Alexander B. Kurzhanski 
Chairman 
System and Decision Sciences Program 
Mathematical Modelling and Analysis of 
Data from Immunological Tests for 
Oncological Patients 
A.L. Asachcnkov, B.G. Sobolcv and E.S. Smolianinov 
Introduction 
A state of the organism during disease is estimated by means of measurement in 
clinical tests which can be considered as observed variables of the mathematical model of 
the process. Functional disturbances to the homeostasis of the organism, which are in- 
duced by the disease, reduce to deviations these variables from the values corresponding 
to the healthy state of the organism. Inspection for the state of the organism during ill- 
ness which is based on an objective analysis of available information is a useful concept 
for choosing the method of treatment [S]. 
An actual problem of clinical oncology is the prediction of individual reaction of a 
tumor process on the method of treatment. At the present time it is not possible to 
predict individual sensitivity of the patients to methods of treatment, and to inspect the 
tumor growth process during treatment using usual statistical methods for processing of 
the clinical data. 
One way to solve this problem consists in construction of an integral index for describ- 
ing the dynamics of the illness as a function of laboratory measured variables. In this work 
we investigate the connection between the dynamics of the observed variables and mortality 
dynamics which is a fundamental development characteristic of tumors [I], [2]. 
In Section 1 some aspects of oncological illness which are important for mathemati- 
cal modelling are studied. Here, mortality dynamics, the stochastic character of the 
dynamic observed variables, heterogeneity population of patients, connection between a 
mortality index and individual dynamic of the laboratory data are discussed. 
In Section 2 a model for describing the dynamics of the observed data is given. The 
method for investigating mortality dynamics as a function of inspecting clinical indices is 
suggested. 
In Section 3, methods for estimating parameters of these models are discussed. 
Then, in Section 4 such an approach is used for analysis on immunological data at 
the patients with stomach cancer. Experimental data was submitted by E.S. Smolianinov 
and N.V. Vasiliev from the Tornsk oncological institute. 
1. Oncological Dieease 
Let us discuss some aspects of the oncological disease which are important for 
mathematical modelling. 
a) After surgery the remaining tumor mass can increase and metastatic spreading 
without expressing clinical symptoms during a long period of months and years. The 
remaining process of tumor growth acting on the main physiological systems of the organ- 
ism reduces to its functional disturbances. 
In turn the organism, to the development of the neoplastic process, responds by 
means of physiological and compensating reactions. These reactions provide stability of 
the basic physiological functions of the organism and guarantee neutralization of infre- 
quent and random disturbances of the homeostatic system. Systematic disturbances in 
most systems of the organism for a long period of time reduce to considerable structural 
and functional disturbances [6],  [7]. 
Consequently, the state of the patients at each instant of time can be considered as a 
point in the space of physiological parameters which are characteristic for functional dis- 
turbances of the homeostatic system. And the disease dynamics can be considered as a 
trajectory in this space. 
One of the system ensuring anti-tumor resistence of the organism, as is known, is 
the immune system. Some immunological indices can be measured in the clinic. We will 
study disease dynamics from the point of view of variation of such immunological indices. 
b) The clinical form of dynamics of oncological illness (aggressive, torpid or slack 
and unprogressive) is characterized by the life span of the patients after surgery. The life 
epan depends on the activity of disease. The main difference of tumor disease from infec- 
tious ones is that the patient's death by infectious disease has more random character 
with respect to these diseases than, as in the first caw, encouraging and morbid forecasts 
are determined by the anti-tumor resistence of the organism. 
Activity of the disease as a rate of the pathological processes can be estimated from 
measurements of the immunological indices. 
If we consider the dynamics of the tumor disease for a group of patients as trajec- 
tories in the space of the parameters we can see breaking trajectories. The instants of 
break of the trajectories have some stable distribution for the stage of illness, method of 
treatment, etc. 
For example, mortality dynamics have a good correlation with the clinical and mor- 
phological estimations of the process (see Fig. 1). 
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Fig. 1. Example of the mortality dynamics with respect to clinical and morphological es- 
timations of the process. (1 - solid tumor; 2 - local mestastatics; 3 - distant metastat- 
ics.) 
Consequently, the index for describing the dynamics of illness must be connected 
with the characteristics of mortality dynamics. 
c) It is very difficult to separate a group of tumor patients which have complete 
functional recovery system and organs and complete clinical recovery after operative pro- 
cedures. Nevertheless to study dynamics of disease in the different groups of patients we 
can compare dynamics of the disease in these groups with dynamics of the patients from 
the group with the best clinical form of disease in which the life span after the beginning 
of treatment is maximum. For example 5 years, because after 5 years a character of de- 
creasing in the group of individuals with the same age is equal to the factor of natural 
death. 
Individual life span after the beginning of treatment depends on the rate of tumor 
process or activity of disease which was investigated by the characteristic deviations of 
immunological indices for patients with a different form of disease from that in the group 
with the best clinical form of disease. Then the contribution of these deviations in the 
mortality dynamics are estimated. 
There are many factors which influence the deviations of individual parameters from 
the trajectory of these parameters in the group of patients with the best clinical form of 
disease that allows us to consider these deviations in the group of patients as realizations 
of some stochastic process. 
Connection between the basic characteristics of disease can formally be represented 
in the following form (Fig. 2). 
Fig. 2. Principal characteristics of the oncological disease. 
From this diagram we can see that the tumor dynamics can be described by means 
of mortality dynamics and the disease activity. We can observe the mortality dynamics 
of a group of patients but the activity disease can only be estimated by means of clinically 
or immunologically measured parameters during illness. 
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1.2. Survivor Function 
Analysis of the processes reduces to patient termination. That allows us to use 
mathematical methods traditionally used for the study of mortality dynamics. More de- 
tailed information can be found in [6], [lo]. 
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Denote by T > 0 a random variable having a continuous distribution function 
F(t)  = P{T 5 t), t > 0. 
Let T be a patient termination time after the beginning of treatment. Mortality 
dynamics in group ie described by a survivor function 
where j(t)  is a probability density function. 
Then the observed group termination intensity or hazard function X(t) is denoted as 
X(t)dt = P{t < T 5 t +  dt 1 T >  t ) .  (1.2) 
Therefore 
t 
S(t)  = exp {- jX(u)du) . 
0 
Integral intensity for the interval [O,t] is 
We will interpret A(t) as a load on the organism due to disease at  the instant of time t. 
Individual dynamics of the disease and intensity of mortality differ from the average 
observed values in the group and can be considered as random. Consequently, we must 
study the factors which generate heterogeneity of the population. In the category of such 
factors we can consider the individual patient dynamics of immunological parameters. 
Let Y(t,w)€Rm denote a vector of immunological parameters for the individual with 
index wEfl measured a t  the instant of time t, where fl is a set of indices, each element of 
which characterizes homogeneity with respect to some indicated group of the individuals. 
Evolution in time { Y(t,w)) on a set of all patients has a random nature. Then the individual 
hazard function ~ ( t , w )  must be a random function with respect to Y(t,w) and t ,  
Individual chances of death in this case are characterized by the conditinal probability 
P { T L  t l (Y(u,w), u 5 t)) (1.7) 
or conditional survivor function 
where Y(u ,w), O< u s  t are individual trajectories of the physiological parameters for those 
patients with the index w on the interval of time [O,t]. If the conditional survivor function 
can be represented in the form of 
then the individual hazard function is 
This function indicates the individual intensity of death connected with the tumor 
process and can be used for analysis of the dynamics of the illness. 
Observations in the group mortality dynamics are connected with average intensity 
of the tumor process for a group of patients. Therefore if the stochastic processes 
are denoted, then the observations in group mortality dynamics can be written in the 
form of 
The following proposition can be made: 
Propoeition 1. [I 01 
Let { Y(t)) be some H-coordinated stochastic process, and p( Y(t,w)) some positive- 
definite function such that V t  
Then 
where T(w) is a random variable connected with the process {Y(t,w)) in the following 
form 
Here 
is u algebra induced by the trajectories of the stochastic process Y(u,w) till the instant of 
time t when H = { H ~ Y ) ~ > ~ .  - 
Consistent with observations for a group of patients, a convenient hazard function is 
given by 
2. Observable Data. Basis Trajectories 
The activity of disease is denoted by a balance between the influence of a tumor on 
the organism and an immune response on a tumor. Some activity of disease can be es- 
timated from observed data, for example clinically measured immunological indices. 
Introduce a new concept - the best clinical form of disease - for which the life span 
after the beginning of treatment is maximum. 
Let the dynamics of the clinically measured immunological indices for the group of 
patients with the best clinical form of disease be described by equation 
where 
z(t)€Rrn is a vector of observable variables ; 
is a vector of coefficience . 
The vector function f(z(t),a) denoted by the analysis of clinically measured data, as 
a rule, has the following form 
Denote q t )  = ft = z(t,ao) a solution of the equation (2.1) under a = ao. This solu- 
tion corresponds to  the average dynamics of the observed data for the group of patients 
with the best clinical form of disease. The solution z(t,ao) is basis or non-perturbed solu- 
tion. 
1 Stochastic model for the deviation from the basia aolution 
Trajectory deviations of the observed data from the basis solution for patients are 
due to the influence on the process of uncontrollable clinical factors. The main role is 
played by a remainder process of the tumor growth and metasthasis. The mathematical 
model for describing such deviations will consist of ordinary differential equations with 
random perturbance in the coefficients. b y  pathological process developed on the same 
physiological foundation as a rule are assumed normal, and differ from normal processes 
only by conditions in the frame of which this process develops. Consequently, the dynam- 
ics of the observable data in the normal and pathological conditions can be described by 
means of the equations with the same structure, and the difference in dynamics is ex- 
plained by the difference between coefficients of the model. 
Let the main source of perturbations be small random deviations of the coefficients cr 
from ao, due to  individual singularity of the organism, i.e., 6a = a - ao. Consequently, 
for a group of patients, a is a random vector with the following form 
where 
E > 0 is a small parameter . 
On the other hand, the source of the perturbations can be continuous perturbations 
of the coefficients of the model by stochastic processes which reflect nonregular diffusion 
influence of difference factors on the organism processes. 
Assume that for each trajectory {zt(w) , WER , tc[O,T]) there exists a function 
at(w) = a. + &(w), where ct(w) is a fast non-regular perturbation. 
Once more the source of the perturbations may be a random deviation of the state 
variables at the instants of time t = 0; for example z0 - J(mo,-yo). 
In this case, the trajectories of the observed variables can be considered as realiza- 
tions of some stochastic process which satisfies the equation 
where the random variables 6a and the random process ct are small. 
As a rule the fluctuations of the coefficients of the model are due to the influence on 
the process of numerous factors. According to the central limit theorem [9] it is reason- 
able to  assume that if these factors occur according to distribution functions, if the effect 
from this influence is small and if these factors are independent then 6a and ct have Gaus- 
sian distributions. Consequently, to  construct a model for deviation of the coefficients we 
don't have to know the mechanism of deviations in detail. Therefore, we assume Gaus- 
sian processes for modelling the fluctuations of the model parameters. 
Proposition 2. [8] 
Let ztcRrn satisfy the system equations 
where 
ct is a stochastic process in R', 
s>O is a small parameter. 
Assume that any trajectories of this process are continuous, and that the function 
f(z,a) has k + l  bounded derivatives with respect to z and a. Then, an approximate of 
the equation (2.3) can be written in the form 
where the functions zl0), zfl), ... are solutions of the equations 
An estimate of the remainder term is given by 
If the model has a form [12] 
where 
and et changing the period of time more less than period of changing of the observable 
variables and one satisfy the condition of strong intermixing, that is dependence between 
C t + ,  tr decreases with the growth of r, then the solution of the equation (2.5) we can 
write in the form 
where z/l) satisfies the stochastic differential 
and consequently 
6Xf = Yf = zf - 2/01 FJ d Z Z / l )  , 
may be approximated by the equation 
When E--+O the process wf is weakly convergent to a Gaussian process wt on the interval 
[O,T] with Ewt = 0. Here, wt is an independent - increment process and the covariance 
matrix Gt[8], where 
In this case, the dynamics of the random deviations Yt = zt - zfO) is approximated 
by the linear stochastic differential 
If the intensity of deviations is small then the individual trajectory is not strong and 
can be withdrawn from the average trajectory zj0) on the finite interval of time [0, TI, and 
the difference between these trajectories has random character. If the intensity of devia- 
tions increases, variance of the deviations increases since 
where H(t,s) is a Green matrix for 
and 
where (,) is an inner product. 
If we have a small systematic deviations vector of coefficients a from the basic 
values ao, the equation for deviations can be shown to have the following form for all 6a: 
Z.Z. Parametrization of the individual hazard function 
The influence of a tumor process on the organism is given by the deviation of physie 
logical parameters from the basis trajectory. Analysis of the observed data shows that 
the character of deviations of parameters from values which typify the best clinical form 
of disease, have a good correlation with mortality dynamics or more exactly with life span 
after the beginning of treatment. In Table 1 the square deviations of the immunological 
data in the different groups of patients are reduced. It is important that 
for all immunological data from Table 1. Using this fact we can parameterize an indivi- 
dual hazard function of the form 
14 Yt,Q) = Y?QY~ + Xo(t) , 
where 
Q - is an unknown symmetrical nonnegative definite matrix of appropriate dimension; 
Xo(t) - is a hazard function which is nonconnected with the tumor process. 
Table 1. Average square of deviations in various groups of patients. 
(-) is a number of patients in group 
Experimental data from Tomsk Oncological Institute, USSR 
Index 
Bcells 
T-cells % 
13-cells % 
Ig G 
A!- 
Ig M 
lim % 
Life span after surgery 
a < 12 months 
7.54 
(75) 
6.86 
(75) 
3.70 
(75) 
6.36 
(75) 
1 
(74) 
b < 36 months 
4.60 
(389) 
3.24 
(389) 
2.71 
(356) 
1.50 
(356) 
0.6 
(388) 
c > 36 months 
0.36 
(62) 
0.19 
(60) 
0.12 
(75) 
0.07 
(25) 
0.1 
(54) 
2.3. Connection of mortality dynamics with dynamics of immunological data 
Assume that the model of the immunological dynamic variables for the best clinical 
form of disease is known. The equations for deviation, in this case, are chosen in the fol- 
lowing form 
where 
Y, = Z ,  - z ~ O ) E R ~  , 
ao( t ) ,  a l ( t ) ,  b ( t )  - are known functions appropriate dimensions. 
If the hazard function has a form pt = Y T Q Y ~ ,  we can construct a system of 
differential equations which connect mortality dynamics with the deviations of immuno- 
logical data from basis trajectories. 
Proposition 3. [I 01 
Let a stochastic process 
satisfy the linear stochastic equation 
d Y t  = (ao ( t )  + a l ( t )  Y t )  dt + I' b ( t )  dwt , 
YO - J4m0,ro) 
and conditional survival function has a form 
where 
Q - is a symmetrical nonnegative definite matrix of appropriate dimension. 
Then the mortality dynamics for a group of patients is described by a system of ordi- 
nary differential equations 
where 
The proof of this proposition is given in [lo]. Therefore, the observable intensity of 
mortality connects with the dynamics of clinically measured variables of the form 
3. Estimating the coefficients of the model 
Let us estimate matrices Q, r  by individual deviations of immunological parameters 
and observable function X(t). 
Functions ao(t), al (t), b (t) are known. 
3.1. Statistical estimation by a patient termination time 
We can define a probability density function f(t) using known functions 
x(t) = mtTgmt + S~[Qrtl , 
Here 
and 
then 
Let B = ( Q , r )  be an unknown vector. Then 
f ( t ;B)  = A(t;B) exp { - A ( t , B ) )  
and the likelihood function is 
d B )  = log P ( ~ ; B )  
where 
In our case 
and the functions m t ( Q ) ,  y t ( r , Q ) ,  At (Q)  are defined in (2.16).  An estimate of the unk- 
nown vector B is given by 
B = arg max p(B) . 
P (3 .8)  
The difficulty of this estimation procedure consists of the following functions 
mt,  y t ,  At is the function of Q .  
3.2. Estimation b y  means of a  joint equation 
In [4 ,  3 ,  121 methods for the estimation of coefficients of the system of O.D.E. 
are discussed. Here zt€IZn, a € R t ,  f(zt,a) = F ( z t ) a .  
The da ta  have the form 
9.2.1. Deterministic case 
Let a = a. + 6a be an unknown vector of coefficients. If zo is known, then the prob- 
lem of estimating a parameter a leads to that of estimating variations 6a from 
6zt = 
- z ( t ,ao). 
Let us consider the case when 6a = const [4 , 31 and in the frame of a given accuracy 
Write the perturbation solution of the system (3.9) z(t,ao + 6a) in power of the 
small parameter. Using methods from [3] write 
where 
a Let A = zf(z(t,ao),ao) be an n x  n matrix, and y;(t) = (ylk(t), .. .,yik(t)) is a vector 
function on [0, TI which satisfies the system 
if j f k  
where 6(t-tk) is the Dirac delta function. In this case 6a is the solution of the system 
(3.11). In [12] the iterative method 
is discussed. This method is actually the celebrated Newton method such as 
where 
Convergence of the estimation is given by 
3.2.2. Stochastic case 
The real trajectories of state variables of the model presumably have stochastic char- 
acter and can not be described in the framework of a deterministic model. The stochastic 
character of the trajectories depends not only on errors of measurements but also on vari- 
ous internal and external factors which influence the process dynamics. The stochastic 
character of real trajectories can be taken into consideration by introducing a random per- 
turbation into the model parameters. In this case a ( t )  = a. + 6a + &Ct is the function of 
time, where {Ct, t€[O,T]) is a stochastic process with ECt = 0 and E>O is a small parame- 
ter. A vector of deviations 6zt(a) has random character so that 
which has approximated a Gaussian probability density function. If the perturbations are 
independent, the mathematical expectation and dispersion have forms of 
where r is a vector of intensity of perturbation. Estimation of the coefficients of the 
model can be obtained from the likelihood function 
In [12] it is proven, that the iterative process 
(6aU, rU) = arg min 4(au,6a,I') , 
6a, r 
is a quasi-Newton process with first-order convergence. The estimations, computed by 
this method, with probability one, converge to the true values a*, r*  when N-too. 
4. Example. Analysis of immunological data of patients with stomach cancer 
In this section, our approach is used for the analysis of immunological data of pa- 
tients with stomach cancer. Experimental data was given by N.V. Vasiliev and E.S. Smo- 
lianinov from the Tomsk oncological institute. We study the dynamics of the tumor pro- 
cess and oncological patients life span after start of the therapy. 
4.1. Preprocessing of clinical data 
The immunological data have a large variability between neighboring instants of 
measurements. This circumstance leads us to  preprocessing of the available data. In 
Table 2 time measured immunological data are given for two methods of treatment. 
Table 2. Time measured immunological data for two methods of treatment in months. 
model time 
t 
$0 6b months 
Method 
chemotherapy 
+ 
surgery 
immune- 
stimulation 
+ 
surgery 
Beg. 
treat- 
ment 
0 
0 
1 
treat- 
ment 
0.5 
- 
Surgery 
1.5 
0.5 
Before and after n courses of treatment 
n= l  
- 
- 
2.0 
n=2 
- 
2.5 
3.0 
3.5 
n=4 
5.0 
5.5 
6.0 
6.5 
n=3 
3.5 
4.0 
4.5 
5.0 
n=10 
23.0 
23.5 
n=5 
7.5 
8.0 
8.5 
9.0 
n=7 
12.5 
13.0 
14.5 
15.0 
n=6 
10.0 
10.5 
11.0 
11.5 
n=8 
16.0 
16.5 
18.0 
18.5 
n=9 
19.5 
20.0 
21.5 
22.0 
Let z j ( t ) ~ ~ ~ ,  j = 1, . . .,M, t E 8  be a vector of measured clinical data from the j-th pa- 
tient. If z(t) is measuring continuously then we can consider the integral of z(t) on [O,t] 
The average value of z(t) on [O,t] is 
We have meaeurements of z(t) only at the discrete set of inatants of time 8 = i t l ,  .. .,tN). 
Then instead of I,(t) we estimate by 
Consequently a set of values of immunological data z = {zt, t ~ 8 )  can be approximated as 
1 - 
a set of values d = {4 = TIz(t), t ~ 8 )  
The variables i ( t )  describe the average dynamics of z(t) in time. 
4.2. Basis dynamics of immunological data 
To study the characteristics of the immune system many tests are performed, but 
not all of these testa are informative for the tumor process. For example, we can use im- 
munological tests of the first level which are measured in the blood of patients such as: 
- concentration of B-cells = zl - T-cells % / B-cells % = z2 - concentration 
of irnmunoglobylius (Ig) of a different class (M,G,A) - IgG = z3 - 
IgAIIgM = z4 - Lymphocytes % = z5 
To construct the basis dynamics of immunological data we use a group of patients 
with life span after operation of not leas than 60 months. Some examples of individual tra- 
jectories for these tests are presented in Fig. 3. 
Fig. 3. Examples of individual trajectories of the immunological data dynarnice from the 
group of patients with the best clinical form of disease. zl is concentration of B-cells; z2 
is 23 is IgG, X4is IgA / IgG, z5 is Lymf. $4, t is time in months. B-cells% ' 
B-cells 
The average dynamics of B-cells after surgery in the group of patients with the best 
clinical form of disease is approximated by equation 
In this case zl(t) decreased from the initial value zlo to the stationary level 
z; = alo/all. On Fig. 4 the solution of the equation (4.5) (continuous curve) and experi- 
mental data ( 0 )  are described. Parameters of equation (4.5) and the initial value was es- 
timated by means of the methods which are discussed in Section 3. 
Fig. 4. Average dynamics of B-cells = zl in the group of patients with the best clinical 
form of disease. The continuous curve is the solution of equation (4.5) and the points ( . ) 
are experimental data (alo = 0.39, all = 0.13, zlo = 6.29). 
T-cells % / B-cells % 
In this case we use equation 
Fig. 5 describes the average dynamic behavior of this variable z2(t). 
Immunoglobulin IgG 
The equation for the average dynamics has the form 
See Fig. 6. 
Fig. 5. Average dynamics of T-cells%/B-cells% in the group of patients with the best 
clinical form of disease. (azo = 0.24, azl = 0.000001, az2 = 0.006, 220 = 2.5). 
Fig. 6. Average dynamics of IgG in the group of patients with the best clinical form of 
disease. (a30 = 0.25, a 3 ~  = 0.15, 230 = 4.13). 
Immunoglubuliue IgA /IgM 
The equation has the form 
The average dynamics for this variable z4( t )  is represented in Fig. 7. 
Fig. 7. Average dynamics of IgA/IgM in the group of patients with the best clinical form 
of disease. (aIO = 0.1, all = 0.00001, = 0.02, 240 = 4.13). 
Fig. 8. Average dynamics of Lymphocyte% in the group of patients with the best clinical 
form of disease. (xS0 = 0.38) 
4.9. Character  of deviations f r o m  average dynamics 
Stable deviation of immunological values from average dynamics is an important 
characteristic of the tumor process. Consider the dynamics of deviations from the basis 
solution in the different groups of patients with respect to life span. 
We expect that small deviations will be characterktic for the patients with the best 
clinical form of disease. For the patients with a short life span after surgery, this devia- 
tions will be greater than in the first group. In Table 1 (Section 2.2) the average square of 
deviations for the different groups is represented. Consequently, we have a correlation 
between the values of deviations from the bask trajectories and life span, moreover the 
value of deviations are significant. Therefore we can study the square of deviations or 
data variance. 
4.4. Immunological data and mortality dynamics 
Using methods from Section 3 and assuming that the matrices Q and r are diagonal 
we have an estimation for Q and f. In our case these estimates have values 
In Fig. 9 the estimation of the survivor function is represented and in Fig. 10 the 
solutions for mi( t ) ,  7 ; ( t ) ,  i = 1, .  . .,4 from the system (2.16) with the estimation Q ,  1' are 
represented. 
Fig. 9. The estimation of the survivor function from (2.16) 
Now, for the individual estimation of the disease activity during treatment we can 
use an index 
Fig. 10. RRsults of estimating of the parameters of the model (2.16) by basis equation 
and survivor function. Lymphocyte% is not used. 
This index can consider the intensity of the pahological process for this level of im- 
munological data deviations. 
In Fig. 11 individual estimations M{ for two different, by life span after surgery, 
groups are represented. 
Fig. 11. Individual estimations M for two groups of patients: a) T 2 40 months, b) 
T < 40 months. 
We can see that the dynamics of the estimation Mt differ in the groups of patients 
with different life spans after the beginning of treatment. The using these estimated in- 
dices we can attempt to control the individual dynamics of the disease during the treat- 
men t . 
5. Discussion 
The method of analysis of disease dynamics for oncological patients is represented in 
this work; the basis on the study of mortality dynamics as a function of immunological 
data deviations allows us to estimate the clinically unexpressed remainder of the tumor 
process and to inspect this process during treatment in individual patients by measuring 
in clincial immunological indices. With the help of such estimations we can solve various 
practical problems such as estimating the state of the organism, investigating the process 
dynamics, comparing the effectiveness of different treatments and formulating the optimal 
control problem for process treatment. But these problems are beyond the frame of this 
presentation. 
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